Equities Analysts Set Expectations for MaxCyte, Inc.'s Q1 2025 Earnings (NASDAQ:MXCT) dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Stephens reaffirmed their equal weight rating on shares of OncoCyte (NASDAQ:OCX – Free Report) in a research report released on Wednesday, Benzinga reports. They currently have a $4.00 price target on the stock. Several other research analysts have also commented on OCX. Benchmark reaffirmed a speculative buy rating and set a $5.00 price objective on […]
MaxCyte, Inc. (LON:MXCT – Get Free Report) insider John Johnston sold 200 shares of the stock in a transaction that occurred on Monday, November 27th. The stock was sold at an average price of GBX 453 ($5.72), for a total transaction of £906 ($1,144.37). MaxCyte Stock Down 0.7 % MXCT opened at GBX 375 ($4.74) […]
StockNews.com started coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a report issued on Saturday morning. The brokerage issued a sell rating on the stock. Several other research firms also recently weighed in on OCX. Benchmark decreased their price target on shares of OncoCyte from $9.00 to $5.00 and set a speculative buy […]
StockNews.com initiated coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a research report released on Tuesday morning. The brokerage issued a sell rating on the stock. Separately, Needham & Company LLC dropped their target price on shares of OncoCyte from $9.00 to $4.25 and set a buy rating for the company in a […]